Yes.

• Click here to download a copy of the Adelante Program Fact Sheet >
• Click here to download a copy of the full CFAR Adelante RFA >

Yes. Please note that in any situation in which the CFAR Adelante program provides funding for team members outside a Team’s research project budget that funding will only be available to the three required team members: Scholar, Collaborating Partner, CFAR Mentor.

Yes, as long as they are a U.S. citizen or permanent resident. Puerto Ricans by birth have U.S. citizenship. Non-U.S. citizen immigrants to Puerto Rico must be U.S. green card holders (permanent residents).

No, unless they have a full-time faculty appointment in place by the time the CFAR Adelante Cohort V project funding begins (June 1, 2023). A letter from the applicant’s future department chair, verifying their faculty position and starting date, must be included in the application package.

No, unless they will have a full-time faculty appointment in place by the time the CFAR Adelante Cohort V project funding begins (August 1, 2023). A letter from the applicant’s department chair, verifying their faculty position and starting date as full-time faculty, must be included in the application package.

Yes, as long as your prior NIH funding has not conferred Independent Investigator status on you. Click here for a list of NIH funding mechanisms that maintain Early Stage Investigator (ESI) status.

No. For purposes of NIH ESI status, a Master in Public Health (MPH) diploma is considered a terminal research degree only in the absence of a doctoral (including MD) degree.

Yes. An applicant is required to have both a CFAR Mentor and a Collaborating Partner in place before submitting a Concept Proposal.

Unfortunately no. There is no single list of senior CFAR-affiliated faculty across the country who are available to be mentors for CFAR Adelante projects

Click here to see a list of currently funded CFARs. Each CFAR has a Developmental Core that is tasked with helping to build the HIV research careers of junior faculty at their institution. As a result, Developmental Core staff are familiar with the senior faculty at their institution and may be able to help you locate an appropriate mentor. CFAR Adelante Pre-award Program Coordinator Allison O’Rourke (EMAIL) may also be able to help you locate a CFAR Mentor.

No. A Team’s CFAR Mentor must have a history of NIH HIV funding as an “independent investigator” (defined by NIH as having been PI on any of these “R01-equivalent” mechanisms: DP1, DP2, DP5, R01, R37, R56, RF1, RL1, U01 and R35) at some point in the past but they do not need to have a current NIH R01-equivalent grant.

Yes. Those letters let the reviewers know that your Team members are enthusiastic about the project and are aware of what their role in it will be. For the Collaborating Partner, we request that letter come from the organization’s Executive Director and/or President.

NOTE: If you have added additional, optional members to your Team, you will need Letters of Support from them as well.

No. A biosketch is only required for the three required members of the team: The Scholar, the CFAR Mentor, and the Collaborating Partner.

Yes. Any otherwise eligible individual that a CFAR Director considers to be a Member of their CFAR is eligible to serve as a CFAR Mentor. A letter from the CFAR Director documenting the membership status of the named CFAR Mentor must be included in the application packet (see RFA for details).

No. Instead, we provide instructional videos.  Click here for more information.

Yes, as long as those study activities comprise only a small subset of your domestic Adelante study.

Please note that any study activities conducted at international sites require international clearance from the NIH. In the past this process has taken anywhere from several weeks to over a year and we are not usually able to predict in advance how long it will take.

No. You can conduct clinical research, but not a clinical trial.

Per the revised NIH definition, a “clinical trial” is a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes.

NOTE: Some, but not all, clinical research funded through Adelante will require additional NIH CFAR review.  See this NIH CFAR page for more information.

Yes. It is perfectly fine for the PI* to use Adelante budget funds for trainings and workshops — the Adelante mechanism is a training grant so using the funds for training purposes is well within its scope.

NOTE: Per the FOA, tuition, stipends, and fees for graduate students is not allowed.

Visit this page on the website >

No. While you must name the Collaborating Partner organization in your concept proposal, you do not have to have the individual who will be representing them named.